NO20070953L - Androgenmodulatorer - Google Patents

Androgenmodulatorer

Info

Publication number
NO20070953L
NO20070953L NO20070953A NO20070953A NO20070953L NO 20070953 L NO20070953 L NO 20070953L NO 20070953 A NO20070953 A NO 20070953A NO 20070953 A NO20070953 A NO 20070953A NO 20070953 L NO20070953 L NO 20070953L
Authority
NO
Norway
Prior art keywords
directed
androgenmodulatorer
benzonitriles
aspects
compounds
Prior art date
Application number
NO20070953A
Other languages
English (en)
Inventor
Bruce Allen Lefker
Raj Kumar Raheja
Yvonne Dorothy Smith
Karen Elaine Sexton
Lai-Yen Hu
Daniel Yunlong Du
Stephen Douglas Barrett
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NO20070953L publication Critical patent/NO20070953L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)
  • Furan Compounds (AREA)

Abstract

Det beskrives en ny klase benzonitriler og deres anvendelse som modulatorer av androgenreseptorer. Andre aspekter med oppfinnelse vedrører anvendelse av disse forbindelser for overskuddssekresjon av sebum, og for å stimulere hårvekst.
NO20070953A 2004-08-31 2007-02-20 Androgenmodulatorer NO20070953L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60589604P 2004-08-31 2004-08-31
PCT/IB2005/002700 WO2006024942A1 (en) 2004-08-31 2005-08-22 Androgen modulators

Publications (1)

Publication Number Publication Date
NO20070953L true NO20070953L (no) 2007-03-20

Family

ID=35453498

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20070953A NO20070953L (no) 2004-08-31 2007-02-20 Androgenmodulatorer

Country Status (15)

Country Link
US (1) US20070207987A1 (no)
EP (1) EP1789408B1 (no)
JP (1) JP2008511606A (no)
KR (1) KR20070049238A (no)
CN (1) CN101044131A (no)
AT (1) ATE392419T1 (no)
AU (1) AU2005278892A1 (no)
BR (1) BRPI0514706A (no)
CA (1) CA2578194A1 (no)
DE (1) DE602005006139T2 (no)
ES (1) ES2302229T3 (no)
IL (1) IL181447A0 (no)
MX (1) MX2007002377A (no)
NO (1) NO20070953L (no)
WO (1) WO2006024942A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1740533A1 (en) 2004-04-22 2007-01-10 Warner-Lambert Company LLC Androgen modulators
MXPA06015169A (es) 2004-07-08 2007-08-21 Warner Lambert Co Moduladores de androgenos.
TW200724139A (en) 2005-05-05 2007-07-01 Warner Lambert Co Androgen modulators

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3164523A (en) * 1961-03-22 1965-01-05 Warner Lambert Pharmaceutical Composition for skin beautification and treatment
DE10218963A1 (de) * 2002-04-27 2003-11-20 Aventis Pharma Gmbh Zubereitungen zur topischen Applikation von antiandrogen wirksamen Substanzen
CA2545048A1 (en) * 2003-11-20 2005-06-02 Warner-Lambert Company Llc Androgen receptor modulators
AU2005214167B2 (en) * 2004-02-13 2008-08-07 Warner-Lambert Company Llc Androgen receptor modulators
BRPI0509759A (pt) * 2004-04-13 2007-10-16 Warner Lambert Co moduladores de androgênio
EP1740533A1 (en) * 2004-04-22 2007-01-10 Warner-Lambert Company LLC Androgen modulators

Also Published As

Publication number Publication date
BRPI0514706A (pt) 2008-06-24
ATE392419T1 (de) 2008-05-15
KR20070049238A (ko) 2007-05-10
AU2005278892A1 (en) 2006-03-09
EP1789408B1 (en) 2008-04-16
JP2008511606A (ja) 2008-04-17
US20070207987A1 (en) 2007-09-06
WO2006024942A1 (en) 2006-03-09
EP1789408A1 (en) 2007-05-30
DE602005006139D1 (de) 2008-05-29
MX2007002377A (es) 2007-04-23
CN101044131A (zh) 2007-09-26
ES2302229T3 (es) 2008-07-01
CA2578194A1 (en) 2006-03-09
DE602005006139T2 (de) 2009-05-07
IL181447A0 (en) 2007-07-04

Similar Documents

Publication Publication Date Title
TW200605876A (en) Androgen modulators
MX2007001993A (es) Moduladores de androgenos.
TW200724139A (en) Androgen modulators
NO20063064L (no) Ny anvendelse av peptidforbindelser for behandling av sentralneurotisk smerte
EA200602221A1 (ru) Новое применение пептидных соединений для лечения боли при тригеминальной невралгии
EA200700702A1 (ru) Аналоги локсапина и способы их применения
EA200601267A1 (ru) Модуляторы рецепторов андрогена
WO2007017754A3 (en) Androgen modulators
BRPI0510177B8 (pt) composto, composição farmacêutica e uso do mesmo
BRPI0509759A (pt) moduladores de androgênio
IS8913A (is) Afleiður 4-tetrazólýl-4-fenýlpiperidíns til þess að meðhöndla verk
GEP20094844B (en) 3-aminocyclopentane carboxamides as modulators of chemokine receptors
EA200700934A1 (ru) Производные пиримидина и их применение в качестве модуляторов cb2
EA200700400A1 (ru) Производные n-(1h-индолил)-1н-индол-2-карбоксамидов, их получение и их применение в терапии
CR9652A (es) Moduladores de alquilquinolina y alquilquinazolina cinasa
CA2562672A1 (en) 4-cyano-phenoxy derivatives as androgen modulators
NO20070953L (no) Androgenmodulatorer
DE602004022935D1 (de) Verbesserungen des stimulationserfolgs-managements
BR0316132A (pt) Método para estimular o crescimento de cabelo utilizando benzopiranos
ATE376416T1 (de) Verwendung von ambroxol zur behandlung von chronischen schmerzen
EA200801407A1 (ru) Модуляторы эстрогена
DOP2005000129A (es) Moduladores de androgenos
MX2007010374A (es) Inhibidor de acat cristalino.
DE60326437D1 (de) Therapeutische verwendung von sapogeninen
FI20030786A0 (fi) VAP-1:n uusi käyttö

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application